share_log

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%), etc.

Bruush Oral Care | SC 13D/A：超過5%持股股東披露文件(修正)-Yaletown Bros. Ventures Ltd.(2.8%),Matthew Friesen(2.8%)等
美股SEC公告 ·  02/24 11:23
牛牛AI助理已提取核心訊息
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
On February 23, 2024, Yaletown Bros. Ventures Ltd, along with individuals Matthew Friesen and Bradley Friesen, filed an Amendment No. 4 to Schedule 13D with the SEC, indicating changes in their ownership of Bruush Oral Care Inc. common shares. The group, which had previously reported ownership stakes ranging from 63% to 82%, now holds approximately 2.8% of the company's common shares, amounting to 2,810,602 shares. This change follows a series of open market transactions between February 16 and February 22, 2024, where the Reporting Persons sold a total of 2,919,500 shares. The transactions included the sale of shares at prices ranging from $0.0575 to $0.0825. The Friesens, through Yaletown Bros. Ventures Ltd, have ceased to be the beneficial owner of more than five percent of Bruush Oral Care's common shares. This filing represents the final amendment to the Schedule 13D for the Reporting Persons, signaling a significant reduction in their investment in the company.
2024年2月23日，Yaletown Bros. Ventures Ltd和個人Matthew Friesen和Bradley Friesen向美國證券交易委員會提交了第4號修正案13D附表，表示他們對Bruush Oral Care Inc.普通股所有權的變更。該團體此前曾報告過持股比例從63%到82%，現在持有公司普通股約2.8%，共計2,810,602股。此次變更是在2024年2月16日至2月22日期間進行了一系列公開市場交易之後發生的，報告人出售了總計2,919,500股股票。交易包括以0.0575至0.0825美元的價格出售股票。Friesens通過Yaletown Bros. Ventures Ltd不再擁有Bruush Oral Care普通股的5%以上的實際所有權。這份申報書代表了報告人對13D附表的最後修正，標誌着他們在公司投資的大幅減少。
2024年2月23日，Yaletown Bros. Ventures Ltd和個人Matthew Friesen和Bradley Friesen向美國證券交易委員會提交了第4號修正案13D附表，表示他們對Bruush Oral Care Inc.普通股所有權的變更。該團體此前曾報告過持股比例從63%到82%，現在持有公司普通股約2.8%，共計2,810,602股。此次變更是在2024年2月16日至2月22日期間進行了一系列公開市場交易之後發生的，報告人出售了總計2,919,500股股票。交易包括以0.0575至0.0825美元的價格出售股票。Friesens通過Yaletown Bros. Ventures Ltd不再擁有Bruush Oral Care普通股的5%以上的實際所有權。這份申報書代表了報告人對13D附表的最後修正，標誌着他們在公司投資的大幅減少。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。